Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Audited (standalone ....
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lincoln Pharmaceuticals Ltd has informed exchanges that a Board meeting is scheduled for May 28, 2026. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board will also consider recommending a dividend on equity shares, if any. The company has closed its trading window from April 01, 2026, which will reopen after 48 hours from when the results become generally available. This is a routine pre-result board meeting intimation filed under SEBI Listing Regulations.
This is a standard board meeting notice announcing the upcoming Q4/FY results date. The dividend consideration is a positive signal for shareholders, though the actual outcome will be known only after the meeting. No specific financial data or audit opinions are disclosed in this filing.